Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus

Lupus

Volumn 16, Issue 7, 2007, Pages 489-496

  Barath, S ^a   Aleksza, M ^a   Tarr, T ^a   Sipka, S ^a   Szegedi, G ^a   Kiss, Emese ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

CD4+CD25high Foxp3+; Constitutional; IL 10; Inducible; Regulatory T cells; SLE

Indexed keywords

INTERLEUKIN 10; MEPREDNISONE; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIGENS, CD4; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY;

EID: 34547800213     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307080226     Document Type: Article

References (33)

1. Tsokos GC, Wong HK, Enyedy EJ, Nambiar MP. Immune cell signaling in lupus. Curr Opin Rheumatol 2000; 12: 355-363.
2. Anolik J, Sanz I. B cells in human and murine systemic lupus erythematosus. Curr Opin Rheumatol 2004; 16: 505-512.
3. Goodnoe CC. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci USA 1996; 93: 2264-2271.
4. + immunoregulatory T cells suppress polyclonal T-cell activation in vitro by inhibiting interleukin-2 production. J Exp Med 1998; 188: 287-296.
5. + cells: a naturally occurring population of regulatory T cells. Blood 2001; 98: 2736-2744.
6. + thymocytes and peripheral T cells have immune suppressive activity. Eur J Immunol 2001; 31: 1247-1254.
7. Sakaguchi S, Takahasi T, Nishizuka Y. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J Exp Med 1982; 156: 1577-1586.
8. + T-cells expressing Foxp3. Diabetes 2005; 54: 1040-1047.
9. Ramsdell F. Foxp3 and natural regulatory cells. Key to a cell lineage? Immunity 2003; 19: 165-168.
10. Bettelli E, Dastrange M, Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kB to repress cytokine gene expression and effector function of T helper cells. Proc Natl Acad Sci USA 2005; 102: 5138-5143.
11. Bakke AC, Purtzer MZ, Wildin RS. Prospective immunological profiling in a case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX). Clin Exp Immunol 2004; 137: 373-378.
12. Saito S, Sasaki Y, Sakai M. CD4 + CD25high regulatory cells in human pregnancy. J Reprod Immunol 2005; 65: 111-120.
13. + regulatory T cells in operational tolerance after living donor liver transplantation. Transplant Proc 2005; 37: 37-39.
14. + regulatory T cells. J Immunol 2004; 172: 5986-5993.
15. Crispin JC, Martinez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2003; 21: 273-276.
16. + T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 2004; 59: 198-202.
17. Miyara M, Amoura Z, Parizot C et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005; 175: 8392-8400.
18. Lee J-H, Wang L, Lin Y, Yang Y, Lin D, Chiang B. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunlogy 2006; 117: 280-286.
19. Soltesz P, Aleksza M, Antal-Szalmas P, Lakos G, Szegedi G, Kiss E. Plasmapheresis modulates Th1/Th2 imbalance in patients with systemic lupus erythematosus according measurement of cytoplasmic cytokines. Autoimmunity 2002; 35: 51-56.
20. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
21. Bombardier C, Gladman D, Urowitz M, Caron D, Chang C and the Committee on Prognosis Studies in systemic lupus erythematsus. Derivation of SLEDAI. A disease activity index for lupus patients. Arthrtitis Rheum 1992; 35: 630-640.
22. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by achieved T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164.
23. Miyara M, Amoura Z, Parizot C et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005; 175: 8392-8400.
24. Karagiannidis C, Akdis M, Holopainen P et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004; 114 (6): 1425-1433.
25. hi T-regulatory cells. Blood 2006; 108: 253-261.
26. Suarez A, Lopez P, Gomez J, Gutierrez C. Enrichment of CD4+CD25+high T cell population in SLE patients treated with glucocorticoids. Ann Rheum Dis 2006; 65: 1512-1517.
27. La Cava A, Fang CJ, Singh RP, Ebling F, Hahn BH. Manipulation of immune regulation in systemic lupus erythematosus. Autoimmunity Rev 2005; 4: 515-519.
28. Hahn BH, Ebling F, Singh RP, Karpouzas G, La Cava A. Cellular and molecular mechanisms of regulation of autoantibody production in lupus. Ann NY Acad Sci 2005; 1051: 433-441.
29. Fields ML, Hindowicz BD, Wharton GN et al. The regulation and activation of lupus associated B cells. Immunol Rev 2005; 204: 165-183.
30. Lee JH, Wang LC, Lin YT, Yang AH, Lin DT, Chiang BL. Inverse correlation between CD4+ regulatory T-cell population and antibody levels in paediatric patients with systemic lupus erythematosus. Immunology 2006; 117: 280-286.
31. + regulatory cells that control intestinal role inflammation. J Exp Med 2000; 192: 295-302.
32. Asseman C, Mauze S, Leach MW et al. An essential rple for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190: 995-1004.
33. Strand V. Biologic agents and innovative interventional approaches in the management of systemic lupus erythematosus. Curr Opin Rheum 1999; 11: 330-340.